Volume : 09, Issue : 12, December – 2022

Title:

88.DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF GABAPENTINE AND NORTRYPTALINE

Authors :

O.Anitha, P.Prapulla

Abstract :

A simple, precise, rapid, specific and accurate stability indicating reverse phase high performance liquid chromatography method was developed for simultaneous estimation of Gabapentin (GPT) and Nortriptyline (NTL) in pharmaceutical tablet dosage form. Chromatographic separation was performed on Agilent C8, (150 X 4.6mm, 5μm) column, with mobile phase comprising of mixture of buffer: (0.1M ammonium acetate) and methanol in the ratio of 70:30v/v, at the flow rate 1.0 ml/min. The detection was carried out at 254 nm. The retention times of GPT and NTL were found to be 2.66 and 3.58 mins respectively with a run time of 6 mins, theoretical levels for GPT and NTL were 8734 and 8648 respectively, with a resolution of 6.56. As per ICH guidelines the method was validated for linearity, accuracy, precision, limit of detection and limit of quantitation, robustness and ruggedness. Linearity of GPT was found in the range of 800-2400 μg/mL and that for CPG was found to be 20-60 μg/mL. The correlation coefficient for GPT and NTL were 0.999 and 1.000 respectively. The LOD values for GPT and NTL were 2.936 and 2.927 μg/mL respectively. The LOQ values for GPT and NTL were and 9.786 and 9.756 μg/mL respectively. This demonstrates that the developed method is simple, precise, rapid, selective, accurate and reproducible for simultaneous estimation of GPT and NTL tablet dosage form.
Keywords: Gabapentin (GPT), Nortriptyline (NTL), RP-HPLC Method Development and Validation

Cite This Article:

Please cite this article in press O.Anitha et al, Development And Validation Of RP-HPLC Method For Simultaneous Estimation Of Gabapentine And Nortryptaline.., Indo Am. J. P. Sci, 2022; 09(12).

Number of Downloads : 10

References:

:

1. FDA Approved Drug Products: Neurontin (gabapentin) for oral use
2. EMA Approved Drugs: Gabapentin
3. Sills GJ: The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006 Feb;6(1):108-13. doi: 10.1016/j.coph.2005.11.003. Epub 2005 Dec 22. (PubMed ID 16376147)
4. Maneuf YP, Luo ZD, Lee K: alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin Cell Dev Biol. 2006 Oct;17(5):565-70. Epub 2006 Sep 24. (PubMed ID 17067834)
5. Kukkar A, Bali A, Singh N, Jaggi AS: Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013 Mar;36(3):237-51. doi: 10.1007/s12272-013-0057-y. Epub 2013 Feb 24. (PubMed ID 23435945)
6. FDA Approved Products: Nortriptyline oral capsules and oral solution
7. Clouse RE: Antidepressants for irritable bowel syndrome. Gut. 2003 Apr;52(4):598-9. doi: 10.1136/gut.52.4.598. (PubMed ID 12631677)
8. Rang, H. P. and Dale, M. M. (2012). Rang and Dale’s Pharmacology (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8)
9. Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. (PubMed ID 7855217)
10. Shaikh, Sultana & Jain, Vandana. (2018). Development and validation of novel RP-HPLC method for simultaneous estimation of gabapentin and amitriptyline hydrochloride in bulk and pharmaceutical dosage forms. International Journal of Applied Pharmaceutics. 10. 97. 10.22159/ijap.2018v10i2.24842.
11. Patel Y., Patel M. B, Patel N.K., Sakhreliya B. Development and Validation of Analytical Method for Simultaneous estimation of Gabapentin and Nortriptyline Hydrochloride in Pharmaceutical Dosage Form. J Pharm Sci Bioscientific Res. 2015 5(5):443-443
12. Gadarajan TVS, Arunkumar N, Aiyalu R, Ponnilavarasan I, Tamilselvi N. Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Gabapentin and Nortriptyline Hydrochloride in Bulk and Tablet Dosage Form. J Young Pharm. 2022;14(2):187-91.